A new Fred Hutch study surprisingly finds that many drugs initially written off as ineffective on cultured cancer cell lines ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have rapidly emerged as highly effective pharmacological tools for ...

When I was a child, there was a TV show called The Six Million Dollar Man. In the opening credits, test pilot Steve Austin ...

Candida infections are becoming harder to treat due to drug resistance. Researchers found EntV, a peptide, weakens the fungus ...

Immunotherapy has transformed the treatment of cancer, yet many patients do not have response or lasting benefit. Strategies ...

Timed release of therapeutic molecules from a soft nanofiber-hydrogel implant supports nerve regrowth and circuit repair ...

By knocking out a protein duo’s “bodyguard” role, researchers have exposed a hidden weakness in pancreatic cancer. It’s a ...

Creeping fat,’ the buildup of fat around the intestines, may worsen Crohn’s disease by fueling inflammation and complicating ...

Chair Zhao Yan is steering the company away from hype-driven marketing, investing in synthetic biology to rebuild growth and ...

Fat is more complicated than we thought. Once considered just a bag of calories, scientists now know that our fat—aka adipose ...

The findings could help explain why for many individuals with Crohn’s disease patients, anti-inflammatories aren’t sufficient to stop the disease.